Evidence map›Paper›PMID 35213729›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS".

Athanasios D Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya A Khan, M Carola Zillikens, Jean-Jacques Body

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Athanasios D AnastasilakisDepartment of Endocrinology, 424 General Military Hospital, Thessaloniki 56429, Greece.ORCID 0000-0002-9624-6296
Jessica PepeDepartment of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Nicola NapoliUnit of Endocrinology and Diabetes, Departmental Faculty of Medicine and Surgery, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Andrea PalermoUnit of Endocrinology and Diabetes, Departmental Faculty of Medicine and Surgery, Campus Bio-Medico University of Rome, 00128 Rome, Italy.ORCID 0000-0002-1143-4926
Christos MagopoulosDepartment of Oral and Maxillofacial Surgery, 424 General Military Hospital, Thessaloniki 56429, Greece.
Aliya A KhanDivision of Endocrinology and Metabolism and Geriatrics, McMaster University, Hamilton, ON L8N 3Z5, Canada.
M Carola ZillikensBone Center, Department of Internal Medicine, Erasmus MC, 2040 Rotterdam, The Netherlands.
Jean-Jacques BodyDepartment of Medicine, CHU Brugmann, Université Libre de Bruxelles, 1050 Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsOsteonecrosisHumansBone Density Conservation Agentsbisphosphonatesbone metastasesdenosumabosteonecrosis of the jawosteoporosis

Identifiers

PMID35213729
PMCPMC9113816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.